You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-ROR-TAK-828F
TAK-828F

Chemical Structure : TAK-828F

CAS No.: 1854901-94-2

TAK-828F (TAK828F;TAK-828)

Catalog No.: PC-63177Not For Human Use, Lab Use Only.

TAK-828F (TAK-828) is a potent, selective, orally available RORγt inverse agonist with binding IC50 of 1.9 nM and reporter IC50 of 6.0 nM, displays excellent selectivity (>5,000-fold) against other ROR isoforms and nuclear receptors.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    TAK-828F (TAK-828) is a potent, selective, orally available RORγt inverse agonist with binding IC50 of 1.9 nM and reporter IC50 of 6.0 nM, displays excellent selectivity (>5,000-fold) against other ROR isoforms and nuclear receptors.
    TAK-828F shows robust and dose-dependent inhibition of IL-17A expression after oral administration at 0.3, 1 and 3 mg/kg bid in the mouse IL-23-induced cytokine expression model.
    TAK-828F also demonstrates dose-dependent inhibition of RORγt regulated gene expression such as IL-17F, IL-22, and IL23 receptor, but no effect against IFN-γ expression.
    TAK-828F significantly reduces the development of clinical symptoms in mouse experimental autoimmune encephalomyelitis model.

    Physicochemical Properties

    M.Wt 509.578
    Formula C28H32FN3O5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20 °C 12 Months; 4°C 6 Months
    In Solvent
    -80 °C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    2-((1S,3s)-3-((R)-5-((7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl)-2-methoxy-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carbonyl)cyclobutyl)acetic acid

    References

    1. Kono M, et al. J Med Chem. 2018 Mar 14. doi: 10.1021/acs.jmedchem.8b00061.

    2. Shibata A, et al. Biochem Pharmacol. 2018 Jan 30;150:35-45.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: